| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 63-74, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
LF Sheu, A Chen, YH Wei, KC Ho, JY Cheng, CL Meng and WH Lee
Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.
About 10% of gastric carcinomas including lymphoepithelioma-like carcinoma and adenocarcinoma are associated with Epstein-Barr virus (EBV) infection. In EBV-associated gastric carcinomas, the tumor cells express Epstein-Barr nuclear antigen 1 (EBNA-1) but not EBNA-2, -3A, - 3B, or -3C, leader protein, or latent membrane proteins (LMPs) because of gene methylation. Only a few exceptional cases have LMP1 expression in tumor cells as demonstrated by immunohistochemical studies. To elucidate the biological effects of LMP1 and the significance of its restricted expression in EBV-associated gastric carcinomas, the LMP1 gene was transferred into EBV-negative gastric carcinoma cell lines (SCM1 and TMC1) and into EBV-negative nasopharyngeal carcinoma (NPC) cells (HONE-1) as a control. The biological effects of LMP1 in gastric carcinoma cells were monitored in vitro and in vivo. These results showed that the consequence of LMP1 expression is a growth enhancement in NPC cells, but it is a growth suppression in gastric carcinoma cells. The LMP1-expressing gastric carcinoma cells had a reduced growth rate, colony-forming efficiency, mean colony size, and tumorigenicity and a lower malignant cytological grade. The reduced growth rate, colony-forming efficiency, and mean colony size were partially reversible in vitro with treatment with LMP1 antisense oligonucleotide. In addition, enhanced apoptosis was found in the LMP1-expressing gastric carcinoma cells. This suggests that LMP1 may negatively modulate the malignant potential of gastric carcinoma cells via an enhancement of apoptosis. We concluded that the restriction of LMP1 expression in EBV-associated gastric carcinomas may lead to a growth advantage for tumor cells by avoiding LMP1 apoptotic effects and immunologically mediated elimination.
This article has been cited by other articles:
![]() |
S.-I. Liu, C.-C. Huang, C.-J. Huang, B.-W. Wang, P.-M. Chang, Y.-C. Fang, W.-C. Chen, J.-L. Wang, Y.-C. Lu, S.-T. Chu, et al. Thimerosal-Induced Apoptosis in Human SCM1 Gastric Cancer Cells: Activation of p38 MAP Kinase and Caspase-3 Pathways without Involvement of [Ca2+]i Elevation Toxicol. Sci., November 1, 2007; 100(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-C. Chan, C.-J. Chen, H.-C. Chu, W.-K. Chang, J.-C. Yu, Y.-J. Chen, L.-L. Wen, S.-C. Huang, C.-H. Ku, Y.-C. Liu, et al. Evaluation of Serum Amyloid A as a Biomarker for Gastric Cancer Ann. Surg. Oncol., January 1, 2007; 14(1): 84 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Niedobitek Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma Mol. Pathol., October 1, 2000; 53(5): 248 - 254. [Abstract] [Full Text] |
||||
![]() |
M. Bonnet, J.-M. Guinebretiere, E. Kremmer, V. Grunewald, E. Benhamou, G. Contesso, and I. Joab Detection of Epstein-Barr Virus in Invasive Breast Cancers J Natl Cancer Inst, August 18, 1999; 91(16): 1376 - 1381. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |